SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Propanc Biopharma Publishes New Data on PRP and Resistant Pancreatic Cancer Cells

Propanc Biopharma says new data show PRP reprograms chemotherapy-resistant pancreatic cancer cells and restores therapeutic vulnerability.

PPCB

Related stories